Parkinson disease trials in Japan

In Japan 9 Also abroad 823

9 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease
Where
Bunkyo-ku, Iruma-gun, Kanagawa, Tokushima, Tokyo
Age
18 years to 69 years
People
100 worldwide
Run by
AbbVie
See details and how to joinNCT07227896
Phase 1Taking people
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
Where
Hachiōji, Tōon, Yufu
Age
30 years to 80 years
People
124 worldwide
Run by
Prevail Therapeutics
See details and how to joinNCT06565195 · EU 2024-513411-27-00
Phase 1Taking people
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Where
Hachiōji, Yufu
Age
30 years to 85 years
People
90 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06809400
Phase 2Not yet taking people in Japan
A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD)
Where
Bunkyo-ku, Kyoto, Nagoya, Toyonaka, Yokohama
Age
45 years to 75 years
People
8
Run by
Bayer
See details and how to joinNCT07566429
Phase 1Taking people
A Clinical Study to Evaluate the Safety of MF1, a New Treatment for Parkinson's Disease-related Disorders (MF1 Study)
Where
Sumida-ku
Age
18 years to 85 years
People
58
Run by
University of Shizuoka
See details and how to joinNCT07666022
No phaseTaking people
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
Where
Akashi
Age
30 years to 99 years
People
60 worldwide
Run by
InSightec
See details and how to joinNCT05539196
No phaseEnrolling by invitation
An Observational Study of Patients With Moderate Parkinson's Disease
Where
Shinjuku-ku, Tokyo
Age
50 years to 68 years
People
96 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT05779475
Phase 1Taking people
A Phase Ib Trial of Combined Febuxostat and Inosine Therapy in Patients With Parkinson's Disease
Where
Toyoake
Age
18 years to 80 years
People
24
Run by
Fujita Health University
See details and how to joinNCT07170475
No phaseTaking people
Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
Where
Gifu
Age
18 years and over
People
350 worldwide
Run by
Kliniken Beelitz GmbH
See details and how to joinNCT04706234